6669 — Acotec Scientific Holdings Share Price
- HK$2.82bn
- HK$2.08bn
- CNY473.85m
- 63
- 20
- 44
- 33
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 26.37 | ||
PEG Ratio (f) | 0.65 | ||
EPS Growth (f) | 67.57% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.91 | ||
Price to Tang. Book | 1.93 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 4.87 | ||
EV to EBITDA | 25.35 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.89% | ||
Return on Equity | 2.43% | ||
Operating Margin | 8.39% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 124.91 | 193.97 | 303.81 | 395.55 | 473.85 | 587.52 | 712.1 | 39.56% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | -79.31 | +366.21 | +47.83 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Acotec Scientific Holdings Ltd is a China-based interventional medical device company. The Company focuses on interventional treatment of vascular diseases, involving Drug-coated Balloons (DCB) and Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) etc. The Company has established a product portfolio for five major therapeutic areas, including vascular surgery, cardiology, nephrology, neurology and andrology. The Company's business covers China, Asia, Europe and other countries and regions.
Directors
- Li Jing CHM (49)
- Silvio Schaffner COO (50)
- Ulrich Speck CTO (80)
- Zhang Hui VPR (44)
- Li Weijia VPR (43)
- Li Chen SEC (31)
- Yi Li Ching SEC
- Chen Chen NED (37)
- Ni Hong NED (48)
- Tang Ke NED (40)
- Yee Poon Kin NED (48)
- Wang Yuqi NED (73)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 3rd, 2020
- Public Since
- August 24th, 2021
- No. of Employees
- 615
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 313,389,171
- Address
- 4F to 5F, Building 1, BEIJING, 100176
- Web
- http://www.acotec.cn/
- Phone
- Auditors
- KPMG
Upcoming Events for 6669
Similar to 6669
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
Arts Optical International Holdings
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:03 UTC, shares in Acotec Scientific Holdings are trading at HK$9.00. This share price information is delayed by 15 minutes.
Shares in Acotec Scientific Holdings last closed at HK$9.00 and the price had moved by -29.02% over the past 365 days. In terms of relative price strength the Acotec Scientific Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -40.69% over the past year.
The overall consensus recommendation for Acotec Scientific Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAcotec Scientific Holdings does not currently pay a dividend.
Acotec Scientific Holdings does not currently pay a dividend.
Acotec Scientific Holdings does not currently pay a dividend.
To buy shares in Acotec Scientific Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$9.00, shares in Acotec Scientific Holdings had a market capitalisation of HK$2.82bn.
Here are the trading details for Acotec Scientific Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6669
Based on an overall assessment of its quality, value and momentum Acotec Scientific Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Acotec Scientific Holdings is HK$22.97. That is 155.22% above the last closing price of HK$9.00.
Analysts covering Acotec Scientific Holdings currently have a consensus Earnings Per Share (EPS) forecast of CNY0.23 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acotec Scientific Holdings. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +14.68%.
As of the last closing price of HK$9.00, shares in Acotec Scientific Holdings were trading +12.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Acotec Scientific Holdings PE ratio based on its reported earnings over the past 12 months is 26.37. The shares last closed at HK$9.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Acotec Scientific Holdings' management team is headed by:
- Li Jing - CHM
- Silvio Schaffner - COO
- Ulrich Speck - CTO
- Zhang Hui - VPR
- Li Weijia - VPR
- Li Chen - SEC
- Yi Li Ching - SEC
- Chen Chen - NED
- Ni Hong - NED
- Tang Ke - NED
- Yee Poon Kin - NED
- Wang Yuqi - NED